As investors pile into psychedelics, idealism gives way to pharma economics

Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental

Related Keywords

Rebekah Mercer ,Chris Yetter ,Rick Doblin ,Carey Turnbull ,Jeffrey Lieberman ,Kabir Nath ,Steven Cohen ,Frederick Barrett ,Peter Thiel ,York University ,Drug Administration ,Atai Life Sciences ,Johns Hopkins University ,Trademark Office ,Public Benefit Corp ,Multidisciplinary Association For Psychedelic ,Columbia University ,New York University ,Dumont Global ,Multidisciplinary Association ,New York Mets ,Benefit Corp ,Compass Pathways ,